EichorEICHOR
Condition: Pneumonia Pneumococcal Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Pneumonia Pneumococcal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial
NA · 3 location(s) · Southern Medical University, China · NCT06699433A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Phase N/A · 54 location(s) · Pfizer · NCT05452941A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months
Phase 1 · 2 location(s) · GlaxoSmithKline · NCT07406334Lebanese Interhospital Pneumococcal Surveillance Program
Phase N/A · 1 location(s) · American University of Beirut Medical Center · NCT00901602Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT04647630Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immuno
Phase 2 · 1 location(s) · University of Utah · NCT05183854
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.